Home > Newsletters > International Pharmaceutical Regulatory Monitor > Parliamentary Report Rips India’s CDSCO on Drug Approvals, Colluding With Industry
International Pharmaceutical Regulatory Monitor
May 2012 | Vol. 40 No. 5
Parliamentary Report Rips India’s CDSCO on Drug Approvals, Colluding With Industry
As many as 33 new drugs approved for use in India between January 2008 and October 2010 — roughly one a month — never underwent clinical trials, according to a scathing parliamentary assessment of the Central Drugs Standard Control Organization (CDSCO) and its drug approval process.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.